A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS
老挝专利「A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS」是 DIP 公开可查的知识产权档案，由 MAHIDOL UNIVERSITY 于 2021-05-05 提交申请，当前状态为等待形式审查。标识字段包括：申请号 P/868；DIP 编号 LAP868；主管局代码 LA；保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-04-03。技术或外观分类记载为 A61K 125/00、A61K 31/12、A61K 31/353、A61K 36/9066、A61P 31/14。发明人 / 设计人包括 BORWORNPINYO, Suparerk、CHABANG, Napason、CHAROENSUTTHIVARAKUL, Sitthivut、CHUTIPONGTANATE, Somchai、HONGENG, Suradej 等。代理机构 / 代理人记载为 Lao Trademark Agency (LAO IP AGENCY)。公开摘要提示：The present invention relates to a pharmaceutical composition capable of inhibiting replication of coronavirus, the composition comprising…。
This Laos patent “A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS” is a public DIP intellectual-property record, filed by MAHIDOL UNIVERSITY on 2021-05-05; current status: Awaiting formal examination. Identifiers include application No. P/868; DIP id LAP868; protection kind Patent - PCT National Phase. Key dates: publication 2026-04-03. Classification: A61K 125/00、A61K 31/12、A61K 31/353、A61K 36/9066、A61P 31/14. Inventor(s)/designer(s): BORWORNPINYO, Suparerk, CHABANG, Napason, CHAROENSUTTHIVARAKUL, Sitthivut, CHUTIPONGTANATE, Somchai, HONGENG, Suradej. Abstract hint: The present invention relates to a pharmaceutical composition capable of inhibiting replication of coronavirus, the composition comprising…. Status labels may change after office actions; refresh or consult primary DIP data before commercial decisions.
ສິດທິບັດ «A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS» ເປັນຂໍ້ມູນຊັບສິນທາງປັນຍາເປີດເຜີຍຂອງ DIP, ຍື່ນໂດຍ MAHIDOL UNIVERSITY ໃນວັນທີ 2021-05-05; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/868; ລະຫັດ DIP LAP868; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-04-03. ປະເພດ/ຫ້ອງ: A61K 125/00、A61K 31/12、A61K 31/353、A61K 36/9066、A61P 31/14. ນັກປະດິດ/ນັກອອກແບບ: BORWORNPINYO, Suparerk, CHABANG, Napason, CHAROENSUTTHIVARAKUL, Sitthivut, CHUTIPONGTANATE, Somchai, HONGENG, Suradej. ສະຫຼຸບ: ການປະດິດສ້າງນີ້ກ່ຽວຂ້ອງກັບອົງປະກອບທາງເພສັສສໍາລັບການຕ້ານເຊື້ອໄວຣັດໂຄໂຣນາ ປະກອບດ້ວຍສານສະກັດກະຊາຍ ທີ່ປະກອບດ້ວຍ ສານແພນດູຣາທິນເອ ( Panduratin A…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.
P/868
图样
基础信息
- 类型
- 专利
- 申请号
P/868- 状态
- 等待形式审查
- 申请人
- MAHIDOL UNIVERSITY
- 代理机构
- Lao Trademark Agency (LAO IP AGENCY)
- 申请日期
- 2021-05-05
- 公开/公告日
- 2026-04-03
- 国际分类
- A61K 125/00 · A61K 31/12 · A61K 31/353 · A61K 36/9066 · A61P 31/14
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
ການປະດິດສ້າງນີ້ກ່ຽວຂ້ອງກັບອົງປະກອບທາງເພສັສສໍາລັບການຕ້ານເຊື້ອໄວຣັດໂຄໂຣນາ ປະກອບດ້ວຍສານສະກັດກະຊາຍ ທີ່ປະກອບດ້ວຍ ສານແພນດູຣາທິນເອ ( Panduratin A ) ແລະ ສານພິໂນສໂຣບິນ (Pinostrobin) ໃນອັດຕາສ່ວນເຊິງໂມຣຢູ່ໃນຊ່ວງ 1 ຕໍ່ 4 ເຖິງ 1 ຕໍ່ 10 ໂດຍອົງປະກອບທາງເພດສັສສໍາລັບຕ້ານໄວຣັດ ໂຄໂຣນາອາດຈະໃຊ້ຮ່ວມກັບຢາຕ້ານໄວຣັດເພື່ອໃຫ້ເສີມປະສົມປະສານກັນ.
The present invention relates to a pharmaceutical composition capable of inhibiting replication of coronavirus, the composition comprising an extract acquired from a plant part of Boesenbergia rotunda, which comprises Panduratin A and Pinostrobin in a molar ratio of 1: 4 to 1 : 10. The pharmaceutical composition may further comprise or being used along with an antiviral agent to achieve a synergistic effect against coronavirus.